Lipocine Inc. Profile Avatar - Palmy Investing

Lipocine Inc.

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions …

Biotechnology
US, Salt Lake City [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
Lipocine Inc. can't present any analysts estimates at the moment detail analysis.
End of LPCN's Analysis
CIK: 1535955 CUSIP: 53630X104 ISIN: US53630X2036 LEI: - UEI: -
Secondary Listings
LPCN has no secondary listings inside our databases.